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Summary
The Trypanosoma brucei procyclic form resides
within the digestive tract of its insect vector, where it
exploits amino acids as carbon sources. Threonine is
the amino acid most rapidly consumed by this para-
site, however its role is poorly understood. Here, we
show that the procyclic trypanosomes grown in rich
medium only use glucose and threonine for lipid bio-
synthesis, with threonine’s contribution being ∼ 2.5
times higher than that of glucose. A combination of
reverse genetics and NMR analysis of excreted end-
products from threonine and glucose metabolism,
shows that acetate, which feeds lipid biosynthesis, is
also produced primarily from threonine. Interestingly,
the first enzymatic step of the threonine degrada-
tion pathway, threonine dehydrogenase (TDH, EC
1.1.1.103), is under metabolic control and plays a key
role in the rate of catabolism. Indeed, a trypanosome
mutant deleted for the phosphoenolpyruvate decar-
boxylase gene (PEPCK, EC 4.1.1.49) shows a 1.7-fold
and twofold decrease of TDH protein level and activ-
ity, respectively, associated with a 1.8-fold reduction
in threonine-derived acetate production. We con-
clude that TDH expression is under control and can
be downregulated in response to metabolic pertur-
bations, such as in the PEPCK mutant in which
the glycolytic metabolic flux was redirected towards
acetate production.
Introduction
Trypanosomes of the Trypanosoma brucei group are the
aetiological agents of Human African trypanosomiasis, a
parasitic disease that affects over 36 countries in sub-
SaharanAfrica (Barrett et al., 2003). The T. brucei life cycle
is complex, and the parasite adapts to life in both its insect
(tsetse fly) and mammalian hosts. These distinct environ-
ments require remodelling of parasite metabolism to
enable adaptation in each. In the glucose-rich environment
of mammalian blood, the bloodstream forms of the parasite
rely solely on glucose to produce energy. The procyclic
forms of the parasite living in the tsetse fly midgut – where
glucose availability is scarce or absent – have developed
an elaborate energy metabolism based on amino acids
such as proline and threonine. In the insect, central energy
metabolism of the procyclic trypanosomes is based on
breakdown of proline, the main carbon and energy source
circulating in haemolymph of the tsetse fly (Coustou et al.,
2008). Threonine, however, is the most abundantly con-
sumed carbon source in procyclics grown in glucose-
depleted conditions (Lamour et al., 2005), but its
contribution and exact role in central metabolism remains
poorly understood.
When grown in standard glucose-rich conditions, procy-
clic trypanosomes prefer D-glucose to L-proline as a carbon
source (Bringaud et al., 2006). As a consequence, the rate
of proline consumption is up to sixfold reduced, with suc-
cinate becoming the main end-product of its metabolism,
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instead of alanine (Lamour et al., 2005; Coustou et al.,
2008). Glucose becomes the major carbon source when
present, being converted by aerobic fermentation to the
partially oxidized end-products, succinate and acetate
(Bringaud et al., 2012). The first seven steps of glycolysis
are sequestered within a peroxisome-like organelle, called
the glycosome (Opperdoes and Borst, 1977; Gualdron-
Lopez et al., 2012). In the course of glycolysis, phospho-
enolpyruvate (PEP) is produced in the cytosol, where it is
located at a branching point to feed the glycosomal ‘succi-
nate branch’ and the mitochondrial ‘acetate and succinate
branches’ (Fig. 1). To produce succinate from glucose,
PEP must re-enter the glycosomes where it is converted
first to oxaloacetate by PEP carboxykinase (PEPCK, EC
4.1.1.49, step 8 in Fig. 1). PEP can also be converted to
pyruvate, which enters the mitochondrion to feed the pyru-
vate dehydrogenase complex (PDH, EC 1.2.4.1, step 3) for
acetyl-CoA production. Most, if not all, of the acetyl-CoA is
then converted into excreted acetate by mitochondrial
acetate:succinate CoA-transferase (ASCT, EC 2.8.3.8,
step 4) and acetyl-CoA thioesterase (ACH, EC 3.1.2.1,
step 5) (Van Hellemond et al., 1998; Riviere et al., 2004;
Millerioux et al., 2012), a canonical tricarboxylic acid cycle
being not operative in these cells (Van Weelden et al.,
2003). ASCT contributes to an important part of mitochon-
drial ATP production through the ASCT/succinyl-CoA syn-
thetase (EC 6.2.1.4) cycle (steps 4 and 6), while ACH does
not (Bringaud et al., 2010; Tielens et al., 2010; Millerioux
et al., 2012). In addition to ATP generation, mitochondrially
derived acetate is essential to feed de novo fatty acid
biosynthesis, through the trypanosomatid-specific acetate
shuttle (Riviere et al., 2009). In this newly discovered
pathway, acetate produced in the mitochondrion is con-
verted back to acetyl-CoA in the cytosol by acetyl-CoA
synthetase (AceCS, EC 6.2.1.1, step 7), to feed the initial
cytosolic step of fatty acid biosynthesis (Riviere et al.,
2009; Vigueira and Paul, 2011).
Threonine metabolism contributes to the production of
acetate in trypanosomes (Cross et al., 1975; Linstead
et al., 1977). According to the current model, this amino
acid is converted to equal amounts of glycine and acetate
in the mitochondrion, although the metabolic pathway
leading to these excreted end-products has not been
investigated using the tools of reverse genetics and meta-
bolic profiling developed during the last decade. Here we
have investigated the threonine degradation pathway in
the procyclic trypanosomes, as well as the contribution of
threonine to acetate and lipid production, using a combi-
nation of reverse genetics approaches [knockout and/or
RNA interference (RNAi) downregulation], analyses of
excreted end-products from these carbon sources by
nuclear magnetic resonance (NMR) spectrometry and
incorporation of radiolabelled carbon sources into lipids by
high performance thin layer chromatography (HPTLC).
Fig. 1. Schematic representation of acetate
metabolism in procyclic trypanosomes grown
in glucose-rich conditions. Black arrows
indicate enzymatic steps of glucose, proline
and threonine metabolism, dashed arrows
symbolize steps supposed to occur at a
background level or not at all, and double line
arrows represent de novo sterol and fatty acid
biosynthesis from acetyl-CoA. Excreted
end-products of metabolism of glucose,
proline and threonine are boxed. Indicated
enzymes are: 1, threonine 3-dehydrogenase
(TDH); 2, 2-amino-3-ketobutyrate coenzyme A
ligase; 3, pyruvate dehydrogenase complex
(PDH); 4, acetate:succinate CoA-transferase
(ASCT); 5, acetyl-CoA thioesterase (ACH); 6,
succinyl-CoA synthetase; 7, AMP-dependent
acetyl-CoA synthetase (AceCS); 8,
phosphoenolpyruvate carboxykinase
(PEPCK). AcCoA, acetyl-CoA; AOB, amino
oxobutyrate; CIT, citrate; DHAP,
dihydroxyacetone phosphate; G3P,
glyceraldehyde 3-phosphate; KG,
2-ketoglutarate; MAL, malate; OA,
oxaloacetate; PEP, phosphoenolpyruvate;
PYR, pyruvate.
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Results
Threonine is the main source of acetate production
It is currently accepted that the procyclic trypanosomes
produce acetate from glucose and threonine (Bringaud
et al., 2006); however, their relative contribution is
unknown and possible involvement of additional carbon
source(s) to acetate production has not been investi-
gated. To address these questions we have developed a
metabolite profiling assay based on the ability of proton
NMR spectrometry to distinguish 13C-enriched from 12C
molecules. Cells were incubated in PBS with equal
amounts (4 mM) of D-[U-13C]-glucose and unenriched
threonine (natural 13C-enrichment is 1.1%), in order to
perform a quantitative analysis of threonine-derived and
glucose-derived acetate production by 1H-NMR. In addi-
tion, the same experiment was performed without threo-
nine, to compare D-[U-13C]-glucose metabolism in the
presence and in the absence of the amino acid. When
glucose is the only carbon source in the incubation
medium, the procyclic trypanosomes excreted mainly
acetate and succinate with traces of pyruvate from
glucose metabolism (Fig. 2A and Table 1). [13C]-Acetate
derived from D-[U-13C]-glucose (annotated A13 in Fig. 2B)
is represented by two doublets, with chemical shifts
at around 2.0 ppm and 1.75 ppm respectively (see
Fig. 2A). The central resonance (1.88 ppm) correspond-
ing to [12C]-acetate, probably derived from an unknown
internal carbon source (11.4% of the excreted acetate;
193 nmol versus 1692 nmol of excreted molecules
h−1 mg−1 of protein), is not included in the quantita-
tive analyses. Addition of threonine to the D-[U-13C]-
glucose/PBS medium induces (i) a huge increase of
[12C]-acetate excretion (3348 nmol versus 193 nmol of
excreted molecules h−1 mg−1 of protein), the difference
(3155 ± 561 nmol) corresponding to threonine-derived
acetate, (ii) a 17.3% reduction of glucose contribution
to acetate production (1240 ± 250 nmol versus 1499 ±
235 nmol of excreted molecules h−1 mg−1 of protein,
P-value < 0.001) and (iii) a 1.6-fold and 2.3-fold increase
Fig. 2. 1H-NMR analysis of excreted
end-products from glucose and threonine
metabolism. Metabolic end-products
(succinate, pyruvate, and acetate) excreted by
the procyclic wild-type cell line (A and B), the
Δpdh mutant (D) and the tetracycline-induced
RNAiTDH.i (C), RNAiTDH/RNAiPDH.i (E) and
Δach/RNAiASCT.i (F) mutants from D-[U-13C]-
glucose and/or threonine was determined by
1H-NMR. The cells were incubated in PBS
containing 4 mM D-[U-13C]-glucose with (_GT)
or without (_G) 4 mM threonine. Each
spectrum corresponds to one representative
experiment from a set of at least 3. A part of
each spectrum ranging from 1.6 ppm to
2.6 ppm is shown (see panels A and C). The
resonances were assigned as indicated in
panels B and F: A12, acetate; A13,
13C-enriched acetate; P12, pyruvate; P13,
13C-enriched pyruvate; S12, succinate; S13,
13C-enriched succinate.
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of succinate and pyruvate excretion from glucose,
probably as a consequence of the observed reduction
of glucose-derived acetate production (Fig. 2B and
Table 1). More importantly, these metabolite analyses
show that, in the presence of equal amounts of threo-
nine and glucose, the amino acid is the main source of
acetate, which contributes approximately 2.5-fold more
to acetate production than glucose (3155 ± 561 nmol
versus 1240 ± 250 nmol of excreted molecules h−1 mg−1
of protein). Unfortunately, we could not determine the
rate of acetate production from threonine in the absence
of glucose, because procyclic cells die within two hours
in PBS/threonine conditions. To get closer to physiologi-
cal conditions, the wild type procyclics were incubated in
the presence of low amounts of threonine (0.2, 0.5 and
1 mM) with equimolar amounts of glycerol, a carbon
source probably present in the insect vector instead of
glucose. In these conditions, threonine remains the main
acetate source regardless of the quantities of carbon
sources available (Fig. S1).
Threonine is the main source for lipid biosynthesis
We previously reported that acetate produced in the mito-
chondrion of procyclic trypanosomes is essential for
de novo fatty acid biosynthesis (Riviere et al., 2009). To
compare the relative contribution of threonine and glucose
to lipid biosynthesis, we determined the radiolabel in-
corporation from D-[U-14C]-glucose, [U-14C]-threonine or
[1-14C]-acetate into fatty acids and sterols in wild-type
procyclic cells incubated for 16 h in SDM79 medium con-
taining equal amounts of glucose and threonine (4 mM).
Fatty acid methyl esters (FAMEs) from total lipids were
formed by trans-esterification, separated from sterols by
HPTLC, and the radiolabelling of FAMEs and sterols was
then determined (Fig. 3). The amounts of threonine incor-
porated into fatty acids and sterols is ∼ 2.5-fold higher than
the amount of glucose incorporated into these molecules,
indicating that threonine is the preferred carbon source for
lipid biosynthesis. This is in agreement with the observed
∼ 2.5 times higher contribution of threonine to the produc-
tion of acetate (Table 1), which is an essential precursor of
de novo fatty acid biosynthesis (Riviere et al., 2009).
Threonine degradation is a non-essential mitochondrial
pathway in standard growth conditions
According to the current model, glucose-derived acetyl-
CoA is produced from pyruvate by the action of the PDH
complex (step 3 in Fig. 1). Acetyl-CoA is then converted in
the mitochondrion into acetate by ASCT (step 4) and ACH
(step 5) (Millerioux et al., 2012). A pathway to produce
acetate from threonine has not been experimentally vali-
dated to date but the T. brucei genome contains the coding
capacity to degrade threonine to acetyl-CoA by threonine
3-dehydrogenase (TDH, EC 1.1.1.103; step 1) and
2-amino-3-ketobutyrate coenzyme A ligase (EC 2.3.1.29,
step 2).Antibodies raised against the T. brucei TDH protein
expressed in Escherichia coli recognize a single 36.5 kDa
protein in Western blots, corresponding to the protein’s
calculated molecular weight (36.96 kDa). Immuno-
fluorescence analyses revealed colocalization with the
mitochondrion-specific dye Mitotracker® Red CMXRos
(Invitrogen) (Fig. 4, upper panel) and known mitochondrial
Fig. 3. [1-14C]-acetate, D-[U-14C]-glucose and L-[U-14C]-threonine
incorporation into lipids of the procyclic trypanosomes. 14C-labelled
fatty acid methyl esters and sterols were separated by HPTLC after
transesterification and analysed as described in the Experimental
procedures section. The EATRO1125.T7T procyclic cells were
incubated 16 h in SDM79 containing 4 mM glucose and 4 mM
threonine with 1 mM acetate and [1-14C]-acetate (lanes A),
D-[U-14C]-glucose (lanes G) or L-[U-14C]-threonine (lanes T) prior to
lipid extraction. The data are expressed as nmol of acetate,
glucose or threonine (radioactive and non-radioactive molecules)
incorporated into fatty acids or sterols in 108 cells per hour. Error
bars indicate mean ± SD of 5 independent experiments.
Fig. 4. Immunolocalization of TDH and PDH. Procyclic cells were
stained with rabbit anti-TDH (Alexa 488 channel) and MitoTracker®
(top panels) or mouse anti-PDH-E1α (Alexa 488 channel) and
rabbit anti-ASCT (Alexa 594 channel) (lower panels). Differential
interference contrast (DIC) of cells is shown to the right of each
panel. Scale bar, 5 μm.
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proteins including the E1α subunit of PDH and ASCT
(Fig. 4, lower panel). The mitochondrial localization of TDH
is consistent with a 24 amino acid N-terminal mitochondrial
targeting signal predicted by MitoProt (http://ihg.gsf.de/ihg/
mitoprot.html) with a high probability (0.82).
Downregulation of the TDH gene in the
EATRO1125.T7T background (RNAiTDH cell line) showed
no growth phenotype upon tetracycline induction (Fig. 5A),
although the TDH enzyme activity and the TDH protein
are no longer detectable up to 12 days after tetracycline
induction (Fig. 5A, insets). Metabolite profiling of the
tetracycline-induced RNAiTDH.i cell line (.ni and .i stand for
non-induced and tetracycline-induced respectively) incu-
bated in the presence of 4 mM of D-[U-13C]-glucose
and unenriched threonine showed a complete abolition
of threonine-derived acetate production, while the rate
of acetate production from glucose reached the value
observed for the wild-type cells incubated in the absence
of threonine (1463 nmol ± 136 versus 1499 ± 235 nmol
of excreted molecules h−1 mg−1 of protein) (Fig. 2C and
Table 1). This demonstrates that TDH is the only route
through which threonine is metabolized to acetate. The
increase of glucose-derived acetate production in the non-
induced RNAiTDH.ni cell line is probably a consequence of
the 2.9-fold decrease in threonine-derived acetate produc-
tion (Table 1), that correlates with a 3.9-fold reduction of
TDH activity (Fig. 5A, inset), presumed to arise from leaky
RNAi expression even under non-induced conditions. The
data demonstrate that TDH and the threonine degradation
pathway are not essential for growth of the parasite, nor is
growth of WT cells affected by removing threonine from the
medium (see Fig. 5D).
Fig. 5. Analysis of mutant cell lines. The figure shows growth curve of the Δpdh null mutant (D) and of the RNAiTDH (A), RNAiPDH (B),
RNAiTDH/RNAiPDH (E) and Δpdh/RNAiTDH (F) mutant cell lines incubated in the presence (.i, ○) or in the absence (.ni, ●) of tetracycline, and
compared with the parental EATRO1125.T7T cell line (WT, ■). Cells were maintained in the exponential growth phase (between 106 and
107 cells ml−1) and cumulative cell numbers reflect normalization for dilution during cultivation. All cell lines were grown in SDM79 medium; the
RNAiPDH (B), Δpdh (D) and WT (D) cell lines were also grown in threonine-depleted conditions (-T). Crosses indicate that all cells were dead.
The insets in panels A–B and D–F show Western blot analyses of the parental (WT) and mutant cell lines with the immune sera indicated in
the right margin. The lower inset in panel A shows the TDH activity (milliunits mg−1 of protein) normalized with the malic enzyme activity
measured in the same samples. Panel C, shows a PCR analysis of genomic DNA isolated from the parental EATRO1125.T7T (WT) and Δpdh
cell lines. Amplifications were performed with primers based on sequences that flank the 5′UTR and 3′UTR fragments used to target the
PDH-E2 gene depletion (black boxes) and internal sequences from the PDH-E2 gene (PCR products 1 and 2), the blasticidin resistance gene
(BSD, PCR products 3–5) or the puromycin resistance gene (PAC, PCR products 6–8). As expected, PCR amplification using primers derived
from the PDH-E2 gene and drug resistant genes were only observed for the parental EATRO1125.T7T and Δpdh cell lines respectively.
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Inhibition of both threonine and glucose degradation is
synthetically lethal
To completely abolish acetate production from both
glucose and threonine metabolism, two complementary
approaches were taken. First, expression of the E2
subunit of PDH (PDH-E2) was successfully downregu-
lated in the RNAiPDH cell line (Fig. 5B, inset) and both
PDH-E2 alleles were replaced by the BSD and PAC
markers in the Δpdh cell line (Fig. 5C and D). Neither cell
line is viable in threonine-depleted medium, while their
growth is not affected in standard threonine-rich medium
(Fig. 5B and D). Second, RNAi-mediated downregulation
of TDH was performed in the RNAiPDH and Δpdh back-
grounds. Both the Δpdh/RNAiTDH and RNAiTDH/RNAiPDH
cell lines die upon tetracycline induction in standard rich
medium (Fig. 5E and F), confirming that abolition of
acetyl-CoA/acetate production from glucose and threo-
nine is lethal for the procyclic trypanosomes grown in
glucose-rich conditions. Addition of 5 mM acetate in the
medium does not rescue growth of the RNAiTDH/RNAiPDH
mutant (data not shown), suggesting that acetate or
acetyl-CoA have to be produced in the mitochondrion to
feed essential pathway(s), such as biosynthesis of mito-
chondrial fatty acids by the prokaryotic-like type II fatty
acid synthase (Guler et al., 2008). In addition, acetate
may participate in the generation of the mitochondrial
membrane potential if exported from the mitochondrion in
its protonated form (Bringaud et al., 2010).
The NMR metabolite profiling of the PDH mutant cell
lines (RNAiPDH.i and Δpdh) incubated in the presence of
both of D-[U-13C]-glucose and unenriched threonine,
revealed that glucose-derived acetate production is 14-fold
reduced (RNAiPDH.i) compared with the parental cells, or
not detectable (Δpdh). As expected, threonine-derived
acetate production is not affected in these mutants
(Table 1, Fig. 2D). In agreement with the current model of
glucose and threonine metabolism, acetate production
from both carbon sources is almost completely abolished
in the Δpdh/RNAiTDH.i and RNAiTDH/RNAiPDH.i cell lines
(Table 1, Fig. 2E). The rate of pyruvate production is con-
siderably increased in all of these PDH-depleted mutants
(up to 4.6-fold), while an increase in succinate production is
moderate (up to 1.2-fold). As expected, pyruvate, the sub-
strate of the targeted enzyme, accumulates in the PDH-
depleted cell lines and is excreted. Succinate production
occurs further upstream in the pathway (see Fig. 1) and is
not significantly affected by PDH-depletion.
Glucose- and threonine-derived acetate branches share
the same last step
We recently demonstrated that glucose-derived acetate is
produced from acetyl-CoA by the action of two redundant
enzymes, acetate:succinate CoA-transferase (ASCT) and
acetyl-CoA thioesterase (ACH) (Millerioux et al., 2012).
RNAi downregulation of ASCT expression in the ACH null
background (Δach/RNAiASCT.i cell line) is lethal and abol-
ished acetate production from glucose. NMR metabolite
profiling of the Δach/RNAiASCT.i cell line incubated in the
presence of 4 mM of D-[U-13C]-glucose and unenriched
threonine, showed 36.5- and 55.4-fold reduction of acetate
production from each of these carbon sources, respec-
tively, after 9 days of tetracycline induction (Fig. 2F and
Table 1). The ∼ 2.5-fold reduction of acetate production
from glucose (492 ± 96 nmol versus 1240 ± 250 nmol of
excreted molecules h−1 mg−1 of protein) and threonine
(1199 ± 236 nmol versus 3155 ± 561 nmol of excreted
molecules h−1 mg−1 of protein) in the uninduced Δach/
RNAiASCT cell line is due to RNAi leakage in addition to ACH
gene deletion (Millerioux et al., 2012). As expected, reduc-
tion of glucose-derived acetate production induced a
notable increase in pyruvate excretion (threefold), even
before tetracycline induction. These data clearly demon-
strate, for the first time, that the last step of acetate pro-
duction catalysed by ASCT and ACH is shared by the
glucose and threonine degradation pathways.
Glycine production from threonine
Linstead et al. previously showed that threonine is con-
verted into equimolar amounts of acetate and glycine
(Linstead et al., 1977). By 1H-NMR, a single glycine reso-
nance (3.52 ppm) is detected near one of the two threonine
doublets (3.56 and 1.28 ppm) (see Fig. S2A, inset).
Although the close proximity of these resonances (3.52
and 3.56 ppm) affects the quantitative analyses of glycine
production and a 2D 1H-NMR approach does not separate
the glycine and threonine resonances (data not shown),
this semi-quantitative analysis reveals that the ratio
between threonine-derived glycine and acetate is
0.88 ± 0.14, confirming that both end-products are
secreted in similar amounts (see Fig. S2A). This ratio is
10-fold increased in the Δach/RNAiASCT.i cell line
(9.51 ± 3.30), while it remains the same in the RNAiTDH.i
and RNAiTDH/RNAiPDH.i mutants (see Fig. S2B and C; quan-
titative data not shown). The higher production of glycine
compared with acetate in the Δach/RNAiASCT.i, is in agree-
ment with the current model (Fig. 1), since glycine is pro-
duced before conversion of acetyl-CoA into acetate by
ASCT and ACH. In addition, we observed that a significant
amount of threonine-derived glycine is incorporated into
trypanothione, which results from the condensation of
spermidine with two glutathione molecules, the latter being
a glycine containing tripeptide. LC-MS metabolic profiling
of intracellular metabolites of the wild-type procyclic cells
incubated with [15N]-threonine show that 26% of the tryp-
anothione molecules are 15N-enriched (data not shown)
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and given that cysteine, glutamate and spermidine, the
other components of trypanothione are not labelled
beyond the natural abundance of 15N, this label must
correspond to the incorporated glycine.
TDH expression is downregulated in the Δpepck mutant
In the procyclic trypanosomes, glucose breakdown pro-
duces PEP, which is converted into two major excreted
end-products, i.e. acetate and succinate (Fig. 1). We
previously manipulated its intermediate metabolism by
redirecting the glycolytic flux towards acetate production
(Ebikeme et al., 2010). This was performed by deleting
the PEPCK gene (Δpepck cell line), which encodes the
first enzymatic step of both succinate branches (step 8).
To identify possible protein expression adaptations in
response to these metabolic changes, we compared the
proteome of the Δpepck and wild-type cells by 2D-DiGE,
as previously described (Alban et al., 2003). This analysis
highlighted a protein species, which was 1.5-fold (P = 4.0
e−6) downregulated in the Δpepck cell line (Fig. S3). This
protein was confidently identified, by tandem mass spec-
trometry and Mascot searching, as TDH (MOWSE score
485, 56% peptide coverage). Modulation of TDH was
confirmed by the 1.7-fold reduction of TDH in the Δpepck
cell line observed by Western blotting with the anti-TDH
and anti-GPDH (control) immune sera (Fig. 6B). The TDH
activity is also downregulated in the Δpepck cell line by a
similar order of magnitude (2.1-fold) (Fig. 6C). Interest-
ingly, downregulation of TDH expression and activity
induces a reduction of threonine’s contribution to acetate
production. Indeed, the ratio between threonine-derived
and glucose-derived acetate production is 1.5-fold
reduced in the Δpepck cell line compared with the wild-
type cells (1.66 versus 2.54) (Fig. 7A and B and Table 1).
This correlation is consistent with the analysis of the RNAiT-
DH.ni cell line showing 3.9-fold and 3.6-fold reduction of
TDH activity and threonine-derived acetate production
respectively (Figs 5A and 7D, Table 1). In addition, 15N-
incorporation into trypanothione is approximately twofold
reduced in the Δpepck cell line compared with the wild-
type parasites (data not shown).
To further confirm the direct correlation between the
TDH protein/activity and threonine-derived acetate pro-
duction, we generated a Δtdh/TDH cell line in which one
allele of the TDH gene was replaced by the puromycin
marker (Fig. 6A). The Δtdh/TDH cell line showed a twofold
and 2.3-fold reduction of the TDH protein levels and activ-
ity respectively (Fig. 6B and C), associated to a twofold
reduction of threonine’s contribution to overall acetate
production (Fig. 7C and Table 1), as observed for the
Δpepck cell line. Figure 8A illustrates the direct correlation
of TDH activity and threonine-derived acetate production
in the wild-type, Δpepck, Δtdh/TDH and RNAiTDH.ni cell
lines. Collectively these data demonstrate that TDH is a
rate-limiting step of the threonine degradation pathway,
which is downregulated in the Δpepck cell line to reduce
contribution of threonine in acetate production.
Uptake of threonine was investigated in the wild-type
and Δpepck cell lines and found that threonine uptake is
similar in both cell lines, as was tyrosine uptake (Fig. 9),
indicating that transport activity is not affected by PEPCK
gene deletion.
Discussion
Threonine is a major carbon source consumed by procyclic
trypanosomes and is converted into equimolar amounts of
glycine and acetate (Cross et al., 1975; Linstead et al.,
1977; and this present analysis). In contrast to glucose and
proline, this amino acid alone cannot sustain growth of the
parasite because it is not a good source for ATP production
Fig. 6. TDH expression and activity are reduced in the Δpepck
cell line. Demonstration of the single TDH allele replacement in the
Δtdh/TDH cell line is presented in panel A. PCR analysis of
genomic DNA isolated from the WT and Δtdh/TDH cell lines was
performed with primers based on sequences that flank the 3′UTR
fragment used to target depletion of one TDH allele (black boxes)
and internal sequences from the TDH gene (PCR product 1) or the
PAC (PCR product 2). As expected, PCR amplification using the
primer derived from the PAC gene was only observed for the
Δtdh/TDH cell line. In panel B, expression of TDH and glycerol
3-phosphate dehydrogenase (GPDH) was analysed by Western
blotting with specific immune sera. Ratio between the TDH and
GPDH signals, indicated below the blot, represents a mean ± SD of
3 different experimental duplicates, with an arbitrary value of 1 for
the parental cells (WT). Panel C shows the PDH (right panel) and
TDH (left panel) activities (milliunits mg−1 of protein), normalized
with the malic enzyme activity measured in the same samples, i.e.
WT, Δpepck and Δtdh/TDH cell lines.
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(Lamour et al., 2005). However, it is the amino acid by far
the most rapidly consumed by procyclic trypanosomes
grown in standard SDM79 medium, with a consumption
rate similar to glucose (Lamour et al., 2005). Here we show
that threonine is the preferred carbon source for lipid
biosynthesis, as previously proposed (Klein and Linstead,
1976), contributing to both the fatty acid and sterol biosyn-
thetic pathways ∼ 2.5 times more than glucose contributes
to the same pathways. This implies that it is degraded to
acetyl-CoAand acetate to feed the initial steps of sterol and
fatty acid biosynthesis, which are respectively located in
the mitochondrion (Carrero-Lerida et al., 2009; Mazet
et al., 2011) and the cytosol (Vigueira and Paul, 2011)
(see Fig. 1). We previously showed that glucose-derived
acetate is produced exclusively inside the mitochondrion
from acetyl-CoA by ASCT and ACH (Millerioux et al.,
2012). Here we show that the same two enzymes produce
acetate from threonine, suggesting that the mitochondrion
is the site for all acetyl-CoA and acetate production in
procyclic form T. brucei. Thus, acetyl-CoA production and
initiation of sterol biosynthesis take place in the same
subcellular compartment; the first three steps of sterol
biosynthesis from acetyl-CoA being catalysed by mito-
chondrial enzymes, i.e. thiolase, 3-hydroxy-3-methyl-
glutary-CoA (HMG-CoA) synthetase and HMG-CoA
reductase (Carrero-Lerida et al., 2009; Mazet et al., 2011).
However, acetyl-CoA must be transferred from the mito-
chondrion to the cytosol to feed the first step of the fatty
acid biosynthetic pathways catalysed by the cytosolic
acetyl-CoA carboxylase (Vigueira and Paul, 2011). This is
achieved by the so-called acetate shuttle, a trypanosoma-
tid specific pathway involving the cytosolic AceCS (Riviere
et al., 2009) (see Fig. 1).
Procyclic trypanosomes are not dependent on threonine
for optimal growth in the standard glucose rich-medium,
where glucose is sufficient to feed lipid biosynthesis.
However, the role of threonine in lipid biosynthesis may be
essential in the insect vector (Glossina species), which
becomes a glucose-free environment 15–30 min after
injection of the blood meal. The doubling time of procyclic
cells grown in medium depleted of glucose, threonine and
pyruvate is significantly reduced compared with glucose/
pyruvate-depleted conditions (18.5 h versus 11.6 h), but
not abolished (Y. Millerioux, M. Mazet, P. Morand and F.
Bringaud, unpubl. data). It is important to note that our
threonine-depleted medium still contains approximately
15 μM threonine derived from the 10% supplement of fetal
calf serum [mammalian blood contains ∼ 150 μM threonine
(Cynober, 2002; Ohnishi et al., 2012)]. This suggests that
either 15 μM threonine is sufficient to feed de novo lipid
biosynthesis or additional carbon source(s) can be used for
lipid biosynthesis, such as other ketogenic amino acids
present in the standard medium as well as in the insect
vector (Balogun et al., 1969; Balogun, 1974), as long as
the corresponding degradation pathway is functional in the
parasite.
Leishmania genomes do not contain the threonine deg-
radation pathways (orthologues of TDH and 2-amino-3-
ketobutyrate coenzyme A genes are absent), suggesting
that they have developed other acetyl-CoA/acetate pro-
duction pathway(s). Leishmania mexicana promastigotes
produce acetate from aspartate (Saunders et al., 2011),
although this pathway has not been described in procyclic
trypanosomes (Berriman et al., 2005). Leishmania prom-
astigotes also produce acetyl-CoA from β-oxidation in their
glycosomes (Gannavaram et al., 2012; Colasante et al.,
Fig. 7. Threonine-derived acetate excretion is reduced in the Δpepck cell line. Metabolic end-products (succinate, pyruvate, and acetate)
excreted by the procyclic wild-type (A), Δpepck (B), Δtdh/TDH (C) and RNAiTDH.ni (D) cell lines from D-[U-13C]-glucose and threonine was
determined by 1H-NMR. The cells were incubated in PBS containing 4 mM D-[U-13C]-glucose and 4 mM threonine. Each spectrum corresponds
to one representative experiment from a set of at least 3. A part of each spectrum ranging from 1.6 ppm to 2.6 ppm is shown. For the
resonances assignment, see Fig. 2.
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2013), although this pathway has also not been demon-
strated in trypanosomes so far (Colasante et al., 2006). In
Leishmania, it has also been shown that leucine is the main
precursor for sterol biosynthesis using an acetyl-CoA inde-
pendent pathway. The same pathway has been shown to
be only weakly active in T. cruzi but has not been investi-
gated in T. brucei so far (Ginger et al., 1999; 2000). Trypa-
nosomes and Leishmania have clearly developed different
strategies to provide acetyl-CoA, which is a key metabolite
linking many biosynthetic and catabolic pathways.
In wild-type procyclic trypanosomes, a direct correlation
is observed between the ratio of the specific activity of
TDH and PDH (2.53; 41.0 mU mg−1 of protein versus
16.2 mU mg−1 of protein) and between the ratio of the
threonine-derived and glucose-derived acetate produc-
tions (2.54; 3155 nmol versus 1240 nmol of excreted
molecules h−1 mg−1 of protein). This suggests that the
metabolic flux through the glucose and threonine branches
is controlled primarily by PDH and TDH activities. The
analysis of the Δtdh/TDH cell line, lacking one TDH allele,
strongly supports this hypothesis since a 58% reduction
of the TDH activity leads to a 57% reduction of acetate
production from threonine. The same correlation is
observed in the RNAiTDH.ni cell line (Fig. 8).Aconsequence
of this metabolic control may be a fine-tuning of acetate
production from the main acetate source, i.e. threonine, in
Fig. 8. Correlation between TDH activity and acetate production.
These graphs show, the percentage of reduction of acetate
production from threonine (panel A) and the percentage of
reduction of the ratio between threonine-derived acetate and
glucose-derived acetate (panel B), as a function of the TDH activity,
in the Δpepck, Δtdh/TDH and RNAiTDH.ni mutants compared with the
wild-type cells. The slope of the curves (y) is close to 1, suggesting
a direct correlation between TDH activity and acetate production
from threonine.
Fig. 9. Threonine uptake. Incorporation of threonine and tyrosine
in the EATRO1125.T7T (black squares) and Δpepck (white square)
cell lines over a two min time period.
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response to the cellular acetyl-CoA or acetate demand
and/or accumulation. Interestingly, TDH downregulation
was observed in the Δpepck cell line, which showed a
redistribution of the glucose metabolic flux towards acetate
excretion, as a consequence of abolition of succinate
production from glucose (see Fig. 1) (Ebikeme et al.,
2010). As observed for the Δtdh/TDH cell line, the 52%
reduction of the TDH activity in the Δpepck mutant is
correlated with the 46% reduction of threonine-derived
acetate production. We propose that redirection of the
glycolytic metabolic flux towards acetate production in
the Δpepck cells induces a signal to downregulate TDH
expression, in order to reduce the contribution of threonine
to acetyl-CoA and acetate production. Collectively, these
data indicate that metabolic flux through the glucose-
derived acetate branch downregulates TDH activity, thus
reducing the contribution of the threonine degradation
pathway in acetyl-CoA and acetate production.
We have previously demonstrated how the availability
of glucose causes diminished activity of proline dehydro-
genase and proline transport (Lamour et al., 2005). Here
it seems that TDH (but not threonine transport) is down-
regulated when glycolytic flux is redirected towards
acetate production. The mechanistic basis of this appar-
ent cross-talk between metabolic pathways has not yet
been investigated.
In mammalian cells, TDH is a key enzyme of acetyl-
CoA metabolism under tight metabolic control. In the rat
liver, for example, regulation of TDH is essential for fatty
acid metabolism and the enzyme is a target of feedback
inhibition by various compounds derived from its major
product, acetyl-CoA (Guerranti et al., 2001), with the
ketone body β-hydroxybutyrate being the most efficient.
Ketone bodies (β-hydroxybutyrate, acetoacetate and
acetone) are water-soluble compounds that are produced
as by-products when fatty acids are broken down for
energy in the liver. β-hydroxybutyrate and acetoacetate
are used as energy sources in the heart and brain while
acetone is a waste product excreted from the body. The
activity of the T. brucei TDH is not affected by up to 10 mM
β-hydroxybutyrate, nor acetate, β-hydroxybutyryl-CoA or
acetyl-CoA (data not shown), suggesting a mechanism of
regulatory control that differs from that in rat liver. Post-
transcriptional and post-translational regulation of TDH
has recently been described in the mouse embryonic
stem cells to modulate somatic cell reprogramming (Han
et al., 2013). In T. brucei reduced TDH activity is corre-
lated with a reduction of TDH protein amounts in the
Δpepck cell line, which suggests a post-transcriptional,
translational or post-translational regulation of its gene
expression. It will be of significant interest to determine
the mechanisms underpinning this regulated gene
expression. Future metabolomic, proteomic and transcrip-
tomic analyses will be useful in determining mechanisms
that underlie reduced expression of TDH in the Δpepck
cell line, or reduced proline dehydrogenase and proline
uptake in wild-type T. brucei procyclics grown in glucose-
depleted conditions. It has recently been demonstrated
that decarboxylated S-adenosylmethionine (dcAdoMet)
contributes directly to regulation of its own cellular abun-
dance in trypanosomes. When levels of this metabolite
decrease, a corresponding increase in translation of the
RNA encoding the regulatory protein called prozyme
occurs and this in turn activates S-adenosylmethionine
decarboxylase, the enzyme responsible for production of
dcAdoMet (Xiao et al., 2013) thus restoring levels of the
diminished metabolite.
Threonine degradation to acetate has also been
described previously in bloodstream forms of T. brucei
(Linstead et al., 1977). To date, the relevance of this
pathway to parasite viability and infectivity have not been
addressed and equivalent experiments to those described
here, on mammalian infective forms of T. brucei are pres-
ently in progress to explore acetate production in blood-
stream form organisms.
Experimental procedures
Growth and maintenance of trypanosomes
The procyclic form of T. brucei EATRO1125.T7T (TetR-HYG
T7RNAPOL-NEO) was cultured at 27°C in SDM79 medium
containing 10% (v/v) heat-inactivated fetal calf serum and
3.5 mg ml−1 hemin (Brun and Schonenberger, 1979) or in a
threonine-depleted SDM79, which still contains threonine
(∼ 15 μM) but only that coming from heat-inactivated fetal calf
serum.
Gene knockout
Replacement of the PEPCK gene (Tb927.2.4210, http://
www.genedb.org/genedb/tryp/) by the blasticidin (BSD) and
puromycin (PAC) resistance markers via homologous recom-
bination was described before (Δpepck cell line) (Ebikeme
et al., 2010). Replacement of the E2 subunit gene of the PDH
complex (PDH-E2: Tb927.10.7570) by BSD and PAC resist-
ance markers via homologous recombination was performed
with DNA fragments containing a resistance marker gene
flanked by the PDH-E2 UTR sequences. Briefly, the pGEMt
plasmid was used to clone an HpaI DNA fragment containing
the BSD and PAC resistance marker gene preceded by the
PDH-E2 5′-UTR fragment (565 bp) and followed by the
PDH-E2 3′-UTR fragment (464 bp). One allele of the TDH
gene (Tb927.6.2790) was replaced by the PAC resistance
marker via homologous recombination with a DNA fragment
containing a resistance marker gene flanked by the TDH
5′-UTR (621 bp) and 3′-UTR (494 bp) sequences. The
PDH-E2 knockout and replacement of one TDH allele were
generated in the EATRO1125.T7T parental cell line, which
constitutively expresses the T7 RNA polymerase gene and
the tetracycline repressor under the control of a T7 RNA
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polymerase promoter for tetracycline inducible expression
(TetR-HYG T7RNAPOL-NEO) (Bringaud et al., 2000). Trans-
fection and selection of drug-resistant clones were performed
as reported previously (Bringaud et al., 1998). Transfected
cells were selected in SDM79 medium containing hygromycin
B (25 μg ml−1), neomycin (10 μg ml−1), blasticidin (10 μg ml−1)
and/or puromycin (1 μg ml−1). The selected cell lines
TetR-HYG T7RNAPOL-NEO Δpdh-e2::BSD/Δpdh-e2::PAC
and TetR-HYG T7RNAPOL-NEO Δtdh::PAC/TDH are called
Δpdh and Δtdh/TDH respectively.
Inhibition of gene expression by RNAi
Inhibition of gene expression by RNAi in procyclic forms
(Ngo et al., 1998) was performed by expression of stem-loop
‘sense/anti-sense’ RNA molecules of the targeted sequences
(Bringaud et al., 2000) introduced in the pLew100 expression
vector (kindly provided by E. Wirtz and G. Cross) (Wirtz
et al., 1999), as previously described. To downregulate
expression of the TDH gene, the pLew-TDH-SAS plasmid
was constructed to target a 408 bp fragment of the TDH
gene (from position 398 bp to 806 bp). Briefly, a PCR-
amplified 501 bp fragment, containing the antisense TDH
sequence with restriction sites added to the primers was
inserted into the HindIII and BamHI restriction sites of the
pLew100 plasmid. Then a PCR-amplified fragment con-
taining the sense TDH sequence (429 bp) was inserted
upstream of the anti-sense sequence, using HindIII and XhoI
restriction sites (XhoI was introduced at the 3′-extremity of
the antisense PCR fragment). The resulting plasmid (pLew-
TDH-SAS) contains a sense and antisense version of the
targeted gene fragment, separated by a 64 bp fragment,
under the control of the PARP promoter linked to a prokary-
otic tetracycline (Tet) operator. For downregulation of the
PDH-E2 gene expression by RNAi, the ‘sense/anti-sense’
cassette of the pLew-PDH-E2-SAS plasmid described before
(Coustou et al., 2008), was introduced into pHD1336 vector,
which contains the blasticidin resistance gene, to generate
the pHD-PDH-E2-SAS plasmid. The RNAiTDH and Δpdh/
RNAiTDH cell lines were produced by introducing the pLew-
TDH-SAS plasmid in the EATRO1125.T7T and Δpdh cell
lines respectively. The RNAiTDH/RNAiPDH double mutant was
produced by transfecting the RNAiTDH cell line with the pHD-
PDH-E2-SAS plasmid. Transfected cells were selected in
SDM79 medium containing, phleomycin (5 μg ml−1; RNAiTDH),
blasticidin (10 μg ml−1; RNAiPDH), phleomycin and blasticidin
(RNAiTDH/RNAiPDH), or puromycin (1 μg ml−1), blasticidin and
phleomycin (Δpdh/RNAiTDH), in addition to hygromycin B
(25 μg ml−1) and neomycin (10 μg ml−1). Downregulation by
RNAi of the ASCT (Tb11.02.0290) gene expression in the
ACH (Tb927.3.4260) null background (Δach/RNAiASCT cell
line) is described elsewhere (Millerioux et al., 2012). Induc-
tion of double-stranded RNA expression was performed by
addition of 1 μg ml−1 tetracycline.
Enzyme assays
TDH enzyme activity was adapted from Linstead et al. (1977)
using a spectrophotometric assay. Briefly, cells were washed
in PBS and resuspended in hypotonic lysis buffer (5 mM
Na2HPO4, 0.3 mM KH2PO4) and sonicated (5 sec at 4°C). The
enzyme assay contained 0.5 mM NAD+, 200 mM Tris HCl pH 8
and 30 mM threonine.As a control, sonicated crude extracts of
trypanosomes were tested for malic enzyme (EC 1.1.1.40)
and PDH activities (Klein et al., 1975; Else et al., 1994).
Production of TDH and PDH antibodies
A recombinant fragment containing the full-length TDH gene
or a fragment of the E1α subunit gene of the PDH complex
(PDH-E1α: Tb927.3.1790), corresponding to positions 415 to
1138 bp of the PDH-E1α gene, were inserted into the NdeI
and BamHI restriction sites of the pET28a (TDH) and pET16b
(PDH-E1α) expression vectors (Novagen), to express in the
BL21 E. coli cell the TDH and PDH-E1α proteins preceded by
a N-terminal histidine tag (6 histidine codons). Cells were
harvested by centrifugation, and recombinant proteins puri-
fied by nickel chelation chromatography (Novagen) from the
insoluble fraction according to the manufacturer’s instruc-
tions. The anti-TDH immune serum was raised in rabbits
by five injections at 15 day intervals of 100 μg of TDH-His
recombinant nickel-purified proteins, emulsified with com-
plete (first injection) or incomplete Freund’s adjuvant (Proteo-
genix S.A.). For PDH-E1α antibodies, mice were immunized
with 10 μg of recombinant nickel-purified proteins by injec-
tion, with complete (first injection) or incomplete Freund’s
adjuvant, into the peritoneum.
Western blot analyses
Total protein extracts of wild-type or mutant procyclic form of
T. brucei (5 × 106 cells) were size-fractionated by SDS-PAGE
(10%) and immunoblotted on Immobilon-P filters (Millipore)
(Harlow and Lane, 1988). Immunodetection was performed
as described (Harlow and Lane, 1988; Sambrook et al.,
1989) using as primary antibodies, the rabbit anti-TDH
(diluted 1:500), the rabbit anti-ASCT (diluted 1:100) (Riviere
et al., 2004), the rabbit anti-GPDH (glycerol 3-phosphate
dehydrogenase, EC 1.1.1.8; diluted 1:100) (Denise et al.,
1999), the mouse anti-hsp60 (diluted 1:10 000) (Bringaud
et al., 1995) and the mouse anti-PDH-E2 (diluted 1:500)
(Ebikeme et al., 2010) and as secondary antibodies, anti-
mouse or anti-rabbit IgG conjugated to horseradish peroxi-
dase (Bio-Rad, 1:5000 dilution). Revelation was performed
using the SuperSignal® West Pico Chemiluminescent Sub-
strate as described by the manufacturer (Thermo Scientific).
Alternatively, for quantitative analyses, revelation was per-
formed using the Luminata™ Crescendo Western HRP Sub-
strate (Millipore). Images were acquired and analysed with a
KODAK Image Station 4000 MM and quantitative analyses
were performed with the KODAK MI application.
Immunofluorescence analyses
Log phase cells were fixed with formaldehyde as described
before (Bringaud et al., 1998). Slides were incubated with
rabbit anti-TDH (diluted 1:100) and Mitotracker®, or mouse
anti-PDH-E1 (diluted 1:50) and rabbit anti ASCT (diluted
1:100) (Riviere et al., 2004) followed by ALEXA Fluor® 594-
conjugated goat anti-mouse secondary antibody (diluted
1:100) and/or ALEXA Fluor® 488-conjugated goat anti-rabbit
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secondary antibody (diluted 1:100) (Molecular Probes),
depending on the analysed cell. Cells were viewed with a
Leica DM5500B microscope and images were captured
by an ORCA®-R2 camera (Hamamatsu) and Leica MM AF
Imaging System software (MetaMorph®) and merged in
Adobe Photoshop on a Macintosh iMac computer.
Proteomics analysis by 2D DiGE
Wild-type and Δpepck cells were harvested from 4 independ-
ent cultures of each line and washed three times in cold
phosphate buffered saline (PBS, pH 7.4). Difference gel elec-
trophoresis analysis was performed as previously described
(Daneshvar et al., 2012) and 2D gel spots were processed for
protein identification as previously described (Bridges et al.,
2008).
NMR experiments
The 108 T. brucei procyclic cells were collected by centrifu-
gation at 1400 g for 10 min, washed once/twice with PBS and
incubated for 6 h at 27°C in 5 ml of incubation buffer (PBS
supplemented with 5 g l−1 NaHCO3, pH 7.4), with D-[U-13C]-
glucose (4 mM) in the presence or the absence of threonine
(4 mM). The integrity of the cells during the incubation was
checked by microscopic observation. Fifty microlitres of
maleate (20 mM) were added as internal reference to a
500 μl aliquot of the collected supernatant and 1H-NMR
spectra were performed at 125.77 MHz on a Bruker DPX500
spectrometer equipped with a 5 mm broadband probe head.
Measurements were recorded at 25°C with an ERETIC
method. This method provides an electronically synthesized
reference signal (Akoka et al., 1999). Acquisition conditions
were as follows: 90° flip angle, 5000 Hz spectral width, 32 K
memory size, and 9.3 s total recycle time. Measurements
were performed with 256 scans for a total time close to
40 min. Before each experiment, phase of ERETIC peak was
precisely adjusted. Resonances of obtained spectra were
integrated and results were expressed relative to ERETIC
peak integration. Protons linked to acetate carbon C2 gener-
ates by 1H-NMR five resonances, a single peak ([12C]-
acetate) flanked by two doublets ([13C]-acetate). When D-[U-
13C]-glucose is the only carbon source (no threonine), the
central resonance (1.88 ppm) corresponding to [12C]-acetate,
probably derived from an unknown internal carbon source. As
a consequence it is not included in the glucose-derived
acetate quantitative analyses (Fig. 2A). Similarly, the [12C]-
succinate resonance (2.35 ppm, annotated S12) observed
between both D-[U-13C]-glucose-derived [13C]-succinate reso-
nances (2.23 ppm and 2.48 ppm, annotated S13) was not
considered (Fig. 2A). The linear production of acetate and
succinate throughout the experiment was confirmed by
1H-NMR quantification of the end-products excreted by the
wild type trypanosomes incubated for 6 h in PBS containing
4 mM [U-13C]-glucose in the presence or absence of 4 mM
threonine (Fig. S4). Data were analysed with the StatPlus
package (AnalystSoft) of the Microsoft Excel software, using
variance analysis followed by Student’s t-test (unpaired,
equal variances) to determine statistical differences in mean
values as indicated in the text. Statistical differences are
significant for P-values < 0.05.
Lipid labelling from D-[14C]-glucose, L-[14C]-threonine
and [14C]-acetate
The 108 cells in the late exponential phase were incubated
for 16 h in 5 ml of modified SDM79 medium containing
4 mM glucose and 4 mM threonine with 25 μCi D-[U-14C]-
glucose (300 mCi mmol−1) or 25 μCi L-[U-14C]-threonine
(175 mCi mmol−1). Alternatively, the cells were incubated
in SDM79 medium containing 4 mM glucose, 4 mM
threonine, 1 mM acetate and 10 μCi of [1-14C]-acetate
(55.3 mCi mmol−1). Cells were checked microscopically for
viability several times during the incubation. Subsequently,
lipids were extracted by chloroform/methanol (2:1, v/v) for
30 min at room temperature, and then washed three times with
0.9% NaCl. The washed lipid extracts were then evaporated
and lipids were dissolved in 1 ml of methanol/H2SO4 (40:1,
v/v). The trans-esterification of the fatty acids of the lipids was
done at 80°C for 60 min. After cooling the samples, 400 μl of
hexane (99% pure) and 1.5 ml of H2O were added, and the
mixture was homogeneized vigorously during 20 sec. The
samples were then centrifuged 5 min at 1000 g to separate
phases, and the hexane upper phases containing FAMEs and
sterols were recovered without contact with the lower phases.
FAMEs and sterols were loaded onto HPTLC plates devel-
oped in hexane/ethylether/acetic acid (90:15:2, v/v) and
sterols (RF 0.20) and FAMEs (RF 0.90) were separated. They
were identified by co-migration with known standards. Their
radiolabelling was then determined with a STORM 860 (GE
Healthcare).
Mass spectrometry analysis of [15N]-threonine
incorporation into intracellular metabolites
Procyclic trypanosomes were kept in log phase growth
(below 2 × 107 ml−1) in threonine-depleted SDM79 medium
containing 5 mM [15N]-threonine (Cambridge Isotope Labora-
tories, 98% 15N-enriched). Intracellular metabolites were
extracted by centrifugation as described before (Vincent
et al., 2012). Samples were analysed on an Exactive Orbitrap
mass spectrometer (Thermo Fisher) in both positive and
negative modes (rapid switching), coupled to a U3000 RSLC
HPLC (Dionex) with a ZIC-HILIC column (Sequant) as has
previously been described (Vincent et al., 2010). All samples
from an individual experiment were analysed in the same
analytical batch and the quality of chromatography and signal
reproducibility were checked by analysis of quality control
samples, internal standards and total ion chromatograms.
The few samples that displayed unacceptable analytical vari-
ation (retention time drift) were removed from further analy-
sis. A standard mix containing approximately 200 metabolites
(including members of the polyamine pathway) was run at the
start of every analysis batch to aid metabolite identification.
Data processing was performed as described before (Vincent
et al., 2012).
Transport assays
Parasites were harvested during the mid-log phase of growth,
by centrifugation at 1250 rcf (2500 r.p.m.) for 10 min and
washed three times with assay buffer (CBSS) by centrifuga-
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tion at 1250 r.p.m. at 4°C. Parasites were resuspended in
assay buffer at the density of 2 × 108 cells ml−1 and kept on
ice, and brought up to room temperature when the experi-
ment was about to proceed. Uptake of radiolabelled com-
pounds was determined using a derivation of the rapid oil/
stop spin protocol, as previously described (Carter and
Fairlamb, 1993). Transport was initiated with 100 μl of cells
being mixed with 100 μl assay buffer, containing radiolabelled
compounds (L-3-3H-threonine was from American Radiola-
belled chemicals at 20 Ci mmol−1 and L-3,5-3H-tyrosine
from Amersham Radiolabelled Chemicals at 49 Ci mmol−1).
To separate trypanosome cells from radiolabelled amino
acid solution, oil was used (1-Bromodo-decane, density:
1.066 g cm−3). The buffer was layered over a 90 μl cushion
of oil. The oil’s density, upon centrifugation, separates the
trypanosome cells from the radioactive medium containing
labelled amino acid. The tube was flash frozen in liquid nitro-
gen, and the pellet was separated from the remnants of the
tube with a tube cutter, and lysed in 200 μl SDS (2%) and
mixed with 3 ml scintillation fluid (Ecoscint A, National Diag-
nostics) and incorporated activity counted after 24 h (to avoid
luminescence) using a liquid scintillation counter (Perkin-
Elmer, liquid scintillation & luminescence counter, Microbeta).
All experiments (at each time point for each substrate) were
carried out, at least, in duplicate, and three times indepen-
dently. Non-transported radiolabelled compounds, associ-
ated with cells or in interstitial spaces, were measured by
performing control uptake determinations on ice (by com-
mencing the reaction at a zero time point using cells, and
buffer kept on ice to ensure, essentially, no uptake).
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